Developer docs
API playgroundTry for free, no card

Search company profiles

Greenfield Pathology Services

Full company profile

uuid002en8u

Namestring
Greenfield Pathology Services
Legal namestring
Greenfield Pathology Services, Inc.
Websiteurl
gfpath.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Greenfield Pathology Services, Inc. (GPS) is a US-based, privately held professional services firm founded in 2019 by Dr. Ken Schafer in Greenfield, Indiana. The company provides GLP-compliant toxicologic pathology services to pharmaceutical companies, Contract Research Organizations (CROs), and small biotech firms. Its service portfolio spans the full preclinical drug development continuum, from discovery and lead optimization through carcinogenicity assessment, including primary pathology evaluation, peer review, expert consulting, white papers, pathology working groups, and regulatory submission advisory.

The technical foundation is the deep expertise of its 14 board-certified ACVP diplomate pathologists (each averaging more than 20 years of experience), covering subspecialties such as ocular, otic, neuropathology, respiratory system, clinical pathology, and carcinogenicity assessment. The core technical work is microscopic evaluation of tissue samples from preclinical drug safety studies, supported by a Contracts Manager handling client engagement. The firm is founder-led, operates from a single office in Greenfield, Indiana, and discloses no external private equity or venture capital backing, no parent company, no subsidiaries, no partnerships, and no intellectual property filings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGreenfield, United States
HQ citystring
Greenfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
toxicologic pathology services, preclinical drug safety, regulatory pathology consulting, nonclinical toxicology assessment, pathology peer review
Industry4 codes
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAFAD
GLP Toxicology (Repeat-Dose, Acute/Subacute)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Toxicologic Pathology Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Pathology Services
TypeProfessional Services
Description

Provides toxicologic pathology services including primary evaluation and peer review of toxicology studies, pathology working groups, expert consulting, and regulatory submission support. Services range from slide evaluation to comprehensive pathology reports for drug development programs.

gfpath.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Greenfield Pathology Services provides GLP-compliant toxicologic pathology consulting for nonclinical drug development, delivered by 14 board-certified ACVP diplomate pathologists. The firm offers primary pathology evaluations, peer review of toxicology studies, specialized expertise in ocular/otic/neuropathology and carcinogenicity assessment, pathology working groups, expert consulting, white papers, and regulatory submission advisory support to pharmaceutical and CRO clients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Greenfield Pathology Services provides regulated toxicologic pathology services as a unified service offering. The company offers a comprehensive portfolio of pathology evaluation and peer review services, supported by a team of experienced, board-certified toxicologic pathologists. Services span the full drug development continuum from discovery and lead optimization through carcinogenicity assessment. Core offerings include primary pathology evaluations, peer review, expert consulting, white papers, pathology working groups, and regulatory submission advisory services. Specialized expertise covers ocular, otic, neuropathology, respiratory system, clinical pathology, and carcinogenicity study assessment. The company was founded in 2019 and serves pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs).

Product and service5 records
1Primary Pathology Evaluation Services
CategoryCore toxicologic pathology service
Description

Expert toxicologic pathology evaluation conducted by board-certified ACVP diplomates, covering all study types from discovery through regulatory submission, for pharmaceutical, biotech, and CRO clients.

2Pathology Peer Review Services
CategoryCore toxicologic pathology service
Description

Independent peer review of toxicology study findings by experienced ACVP diplomates to ensure scientific rigor and regulatory compliance for nonclinical studies.

3Expert Consulting and White Papers
CategoryConsulting service
Description

Professional consulting services and expert-authored white papers on toxicologic pathology matters for regulatory submissions and drug development programs.

4Pathology Working Groups
CategoryCollaborative consulting service
Description

Collaborative pathology working group engagements bringing together multiple expert pathologists from the firm's bench to address complex toxicology questions for clients.

5Regulatory Submission Advisory
CategoryRegulatory consulting service
Description

Guidance and advice on pathology aspects of regulatory submissions to support drug development, approval processes, and interactions with regulatory authorities.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Preclinical CRO focused on toxicology and safety assessment with related pathology services. Smaller-scale, niche US-based competitor overlapping with GPS' regulatory-grade positioning.

TypeBroad incumbent
Description

Global preclinical CRO with large toxicologic pathology group within its Safety Assessment segment. Competes for the same pharma and biotech pathology engagements GPS targets, typically as part of full-service toxicology studies.

TypeBroad incumbent
Description

Preclinical CRO offering toxicology, pathology, and research models with integrated toxicologic pathology services. A scaled, multi-modality competitor that bundles pathology into broader preclinical packages.

TypeDirect peer
Description

Specialty GLP-compliant histopathology and toxicologic pathology services provider. Closely comparable niche positioning to GPS, focused on regulated preclinical tissue evaluation for drug development.

TypeBroad incumbent
Description

One of the largest preclinical CROs globally with in-house toxicologic pathology teams serving global pharma sponsors. Represents both a competitor and a potential partner/subcontractor for overflow pathology work.

TypeBroad incumbent
Description

Global CRO/CDMO with preclinical toxicology and pathology capabilities serving both large pharma and small biotech. While China-headquartered, its US operations compete for outsourced pathology work.

TypeDirect peer
Description

Long-standing US toxicologic and anatomic pathology CRO providing peer review, primary evaluation, and PWG services to pharma and biotech. EPL is the most direct like-for-like competitor to GPS' core toxicologic pathology offering.

TypeBroad incumbent
Description

Provides preclinical and veterinary pathology, including toxicologic pathology support for pharma and device sponsors. Comparable pathology expertise, broader menu of related laboratory services.

9Seventh Wave Laboratories
TypeDirect peer
Description

Mid-sized preclinical CRO offering toxicology, pathology, and bioanalysis services to pharma/biotech. Comparable boutique-to-mid-scale positioning with in-house toxicologic pathology capabilities.

TypeDirect peer
Description

Veterinary and toxicologic pathology consulting practice serving pharma and chemical industries with peer review, study evaluation, and regulatory pathology support. Closely analogous boutique service model to GPS.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Greenfield Pathology Services

Toxicologic Pathology Servicesgfpath.com

What Greenfield Pathology Services does

Greenfield Pathology Services, Inc. (GPS) is a US-based, privately held professional services firm founded in 2019 by Dr. Ken Schafer in Greenfield, Indiana. The company provides GLP-compliant toxicologic pathology services to pharmaceutical companies, Contract Research Organizations (CROs), and small biotech firms. Its service portfolio spans the full preclinical drug development continuum, from discovery and lead optimization through carcinogenicity assessment, including primary pathology evaluation, peer review, expert consulting, white papers, pathology working groups, and regulatory submission advisory.

The technical foundation is the deep expertise of its 14 board-certified ACVP diplomate pathologists (each averaging more than 20 years of experience), covering subspecialties such as ocular, otic, neuropathology, respiratory system, clinical pathology, and carcinogenicity assessment. The core technical work is microscopic evaluation of tissue samples from preclinical drug safety studies, supported by a Contracts Manager handling client engagement. The firm is founder-led, operates from a single office in Greenfield, Indiana, and discloses no external private equity or venture capital backing, no parent company, no subsidiaries, no partnerships, and no intellectual property filings.

Greenfield Pathology Services firmographics

Firmographics
Name
Greenfield Pathology Services
Legal name
Greenfield Pathology Services, Inc.
Website
https://gfpath.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Greenfield Pathology Services industry classification

Industry
Product category
Toxicologic Pathology Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAFAD
GLP Toxicology (Repeat-Dose, Acute/Subacute)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Toxicologic pathology services
  • Preclinical drug safety
  • Regulatory pathology consulting
  • Nonclinical toxicology assessment
  • Pathology peer review

Where Greenfield Pathology Services is headquartered

Location

Headquarters

HQ city
Greenfield
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Greenfield Pathology Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Professional Pathology Services: Provides toxicologic pathology services including primary evaluation and peer review of toxicology studies, pathology working groups, expert consulting, and regulatory submission support. Services range from slide evaluation to comprehensive pathology reports for drug development programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Greenfield Pathology Services product offering

Product offering

Core offering

Greenfield Pathology Services provides GLP-compliant toxicologic pathology consulting for nonclinical drug development, delivered by 14 board-certified ACVP diplomate pathologists. The firm offers primary pathology evaluations, peer review of toxicology studies, specialized expertise in ocular/otic/neuropathology and carcinogenicity assessment, pathology working groups, expert consulting, white papers, and regulatory submission advisory support to pharmaceutical and CRO clients.

Product overview

Greenfield Pathology Services provides regulated toxicologic pathology services as a unified service offering. The company offers a comprehensive portfolio of pathology evaluation and peer review services, supported by a team of experienced, board-certified toxicologic pathologists. Services span the full drug development continuum from discovery and lead optimization through carcinogenicity assessment. Core offerings include primary pathology evaluations, peer review, expert consulting, white papers, pathology working groups, and regulatory submission advisory services. Specialized expertise covers ocular, otic, neuropathology, respiratory system, clinical pathology, and carcinogenicity study assessment. The company was founded in 2019 and serves pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs).

Differentiator

Problem solved

Functional benefit

Products and services

  • Primary Pathology Evaluation Services Expert toxicologic pathology evaluation conducted by board-certified ACVP diplomates, covering all study types from discovery through regulatory submission, for pharmaceutical, biotech, and CRO clients.
  • Pathology Peer Review Services Independent peer review of toxicology study findings by experienced ACVP diplomates to ensure scientific rigor and regulatory compliance for nonclinical studies.
  • Expert Consulting and White Papers Professional consulting services and expert-authored white papers on toxicologic pathology matters for regulatory submissions and drug development programs.
  • Pathology Working Groups Collaborative pathology working group engagements bringing together multiple expert pathologists from the firm's bench to address complex toxicology questions for clients.
  • Regulatory Submission Advisory Guidance and advice on pathology aspects of regulatory submissions to support drug development, approval processes, and interactions with regulatory authorities.

Companies that use Greenfield Pathology Services

Customer profile

Segments3 records

Ideal customer profiles3 records

Greenfield Pathology Services technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Greenfield Pathology Services partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves1 record

Expansion highlights3 records

Greenfield Pathology Services competitors and assessment

Company assessment

Emerging players

  • MB Research Laboratories: Preclinical CRO focused on toxicology and safety assessment with related pathology services. Smaller-scale, niche US-based competitor overlapping with GPS' regulatory-grade positioning.

Broad incumbents

  • Charles River Laboratories: Global preclinical CRO with large toxicologic pathology group within its Safety Assessment segment. Competes for the same pharma and biotech pathology engagements GPS targets, typically as part of full-service toxicology studies.
  • Inotiv: Preclinical CRO offering toxicology, pathology, and research models with integrated toxicologic pathology services. A scaled, multi-modality competitor that bundles pathology into broader preclinical packages.
  • Labcorp Drug Development (formerly Covance): One of the largest preclinical CROs globally with in-house toxicologic pathology teams serving global pharma sponsors. Represents both a competitor and a potential partner/subcontractor for overflow pathology work.
  • WuXi AppTec: Global CRO/CDMO with preclinical toxicology and pathology capabilities serving both large pharma and small biotech. While China-headquartered, its US operations compete for outsourced pathology work.
  • IDEXX BioAnalytics: Provides preclinical and veterinary pathology, including toxicologic pathology support for pharma and device sponsors. Comparable pathology expertise, broader menu of related laboratory services.

Direct peers

  • HistoTox Labs: Specialty GLP-compliant histopathology and toxicologic pathology services provider. Closely comparable niche positioning to GPS, focused on regulated preclinical tissue evaluation for drug development.
  • EPL Inc. (Experimental Pathology Laboratories): Long-standing US toxicologic and anatomic pathology CRO providing peer review, primary evaluation, and PWG services to pharma and biotech. EPL is the most direct like-for-like competitor to GPS' core toxicologic pathology offering.
  • Seventh Wave Laboratories: Mid-sized preclinical CRO offering toxicology, pathology, and bioanalysis services to pharma/biotech. Comparable boutique-to-mid-scale positioning with in-house toxicologic pathology capabilities.
  • Vet Path Services (VPS): Veterinary and toxicologic pathology consulting practice serving pharma and chemical industries with peer review, study evaluation, and regulatory pathology support. Closely analogous boutique service model to GPS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Greenfield Pathology Services social profiles

Digital presence

Greenfield Pathology Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Greenfield Pathology Services leadership team

Management profile

Number of profiles

Profiles15 records

Greenfield Pathology Services funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Greenfield Pathology Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Greenfield Pathology Services

What does Greenfield Pathology Services do?

Greenfield Pathology Services provides GLP-compliant toxicologic pathology consulting for nonclinical drug development, delivered by 14 board-certified ACVP diplomate pathologists. The firm offers primary pathology evaluations, peer review of toxicology studies, specialized expertise in ocular/otic/neuropathology and carcinogenicity assessment, pathology working groups, expert consulting, white papers, and regulatory submission advisory support to pharmaceutical and CRO clients.

Is Greenfield Pathology Services a public or private company?

Greenfield Pathology Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Greenfield Pathology Services founded?

Greenfield Pathology Services was founded in 2019. It employs 11 to 50 people.

Where is Greenfield Pathology Services based?

Greenfield Pathology Services is headquartered in Greenfield, United States, in the North America region.

How does Greenfield Pathology Services make money?

One revenue line is on record: professional Pathology Services.

Who are Greenfield Pathology Services's main competitors?

MB Research Laboratories is listed as an emerging player. Broad incumbents are Charles River Laboratories, Inotiv, Labcorp Drug Development (formerly Covance), WuXi AppTec and IDEXX BioAnalytics. Direct peers are HistoTox Labs, EPL Inc. (Experimental Pathology Laboratories), Seventh Wave Laboratories and Vet Path Services (VPS).

Does Greenfield Pathology Services have an API?

No public API is recorded for Greenfield Pathology Services.

What industry is Greenfield Pathology Services in?

Greenfield Pathology Services's product category is Toxicologic Pathology Services. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services, with a secondary code of HLAGAFAD, GLP Toxicology (Repeat-Dose, Acute/Subacute). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales